Antengene Corporation Revenue

In the year 2025, Antengene Corporation had annual revenue of 105.34M CNY with 14.56% growth. Antengene Corporation had revenue of 52.16M in the half year ending December 31, 2025, a decrease of -1,207.11%.

Revenue

105.34M CNY

Revenue Growth

+14.56%

P/S Ratio

29.38

Revenue / Employee

816.57K CNY

Employees

129

Market Cap

3.44B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	105.34M	13.39M	14.56%
Dec 31, 2024	91.95M	24.65M	36.62%
Dec 31, 2023	67.31M	-92.83M	-57.97%
Dec 31, 2022	160.14M	131.37M	456.62%
Dec 31, 2021	28.77M	-	-
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Viva Biotech Holdings	1.92B
BioDlink International Company	831.99M
Mirxes Holding Company	166.32M
TYK Medicines	117.25K
Clover Biopharmaceuticals	3.90M
Qyuns Therapeutics	897.99M
Jiangsu Recbio Technology	14.16M
Medtide	634.40M

Revenue Rankings

Antengene Corporation News

2 months ago - Antengene Corporation Transcript: Status update - Transcripts
4 months ago - Antengene Secures Malaysian Approval For XPOVIO In Relapsed/Refractory DLBCL - Nasdaq
5 months ago - Antengene: NMPA Approves IND Application For Phase Ib/II CLINCH-2 Study With ATG-022 - Nasdaq
4 years ago - Antengene Corporation Transcript: R&D Day 2021 - Transcripts

More News